Alcohol Use Disorder at AAAP 37th Annual Meeting and Scientific Symposium

Thursday, November 12

• 09:00–10:40 · Symposium

  Symposium I - From Metabolism to Addictions: Repurposing GLP-1 Therapies for Alcohol and Other Substance Use Disorders

  Lorenzo Leggio · Joji Suzuki · Luba Yammine · Manish Jha

  Reviews preclinical, observational and early randomized trial evidence on using GLP-1 receptor agonists to treat alcohol and other substance use disorders, including psychiatric safety.

  GLP-1 & Metabolic Psychiatry · Substance Use Disorders

Sunday, November 15

Posters (14)

• Beyond Weight Loss: GLP- 1 Receptor Agonists for Alcohol Use Disorder- A Systematic Review and Meta-Analysis — Ramita Goel
• Alcohol Use Disorder and Binge Eating as Maladaptive Coping Strategies in a Young Adult with Autism Spectrum Disorder: A Case Study in the Complexity of Addiction at the Neurodevelopmental Interface — Majd Al-Soleiti
• Expanding the Therapeutic Landscape of Alcohol Use Disorder: Brenipatide (Dual GIP/GLP-1 Receptor Agonist) Clinical Trials — Marc Fishman
• Impulsivity and Alcohol Use in Veterans with Co-occurring AUD and PTSD: Variations Before, During, and after Treatment — Edith Harris
• GLP-1 Receptor Agonists in Alcohol Use Disorder: Outcome-Domain Synthesis With Exploratory Aggregate-Data Pooling of Randomized Trials — Mahnoor Waqar
• Effect of L-Cysteine Supplementation on Acetaldehyde Exposure following Ethanol Administration: A Systematic Review and Meta-Analysis — Lucas Heilbroner
• Effects of Alcohol Use on Cognition During Later Adulthood — Shivani Raman
• Large Language Models Applied to Admissions Data May Identify Patients at High Risk for Alcohol Withdrawal Syndrome — Natalie Swartz
• Pregabalin: A True Dual Diagnosis Medication? Perspectives from a Case of Successful Treatment with Pregabalin in a Patient with Comorbid Alcohol Use Disorder, Anxiety, and Primary Insomnia — Lindsey d'Arnaud
• National Trends in Management of Alcohol Withdrawal Syndrome across Vha following the Implementation of a Toolkit — Brian Fuehrlein
• Real-World Treatment Patterns of Patients Initiating Pharmacotherapy for Alcohol Use Disorder across Medicare, Medicaid, and Commercial Insurance — Valentine Pascale
• The Socioeconomic Paradox of Substance Use: High Income and Education as Independent Risk Factors for Alcohol Use Disorder in U.S. Adults (2021-2024) — Dania Mofleh
• Accelerated Resolution Therapy as an Adjunctive Treatment Modality for Comorbid Alcohol Use Disorder and Posttraumatic Stress Disorder: A Scoping Review — Jaqueline Campbell
• Psychosis or Encephalopathy? Addiction Psychiatry Challenges in Co-Occurring Schizophrenia, Alcohol Use Disorder, and Decompensated Liver Disease — Fnu Shashi Kant

Schedule to be announced

• Symposium · Symposia

  From Metabolism to Addictions: Repurposing GLP-1 Therapies for Alcohol and Other Substance Use Disorders

  Lorenzo Leggio · Joji Suzuki · Luba Yammine · Manish Jha

  Surveys preclinical and emerging clinical evidence for GLP-1 receptor agonists as candidate treatments for alcohol and other substance use disorders.

  GLP-1 & Metabolic Psychiatry · Substance Use Disorders